Novo Nordisk prepares to report next-generation weight-loss drug results
The Danish company is lining up a readout as it works to defend share in the incretin market against Eli Lilly.
MH
By Maren Holt · Senior Reporter, GLP-1
Oct 13 01:48 ETSource: BusinessWorld Online
The wire
- 01BusinessWorld reports Novo Nordisk is readying trial results for a next-generation weight-loss candidate.
- 02Any new Novo readout shapes prescribing options and payer negotiations for clinicians and telehealth operators managing obesity patients.
- 03Details on the candidate, trial design and timing were not specified, so the magnitude of the result remains unknown until data are published.
From the source
Read at bworldonline.comnovo nordisk readies trial results for next-generation weight-loss drug
